Abstract:Background Gliomas are recalcitrant brain tumors. Anti-glioma immunity and immunopathogenic responses are critical contributors for better survival of isocitrate dehydrogenase-mutant (IDHmut) over wild-type (IDHwt) gliomas. Despite this correlative pattern of immunity and survival, an unbiased understanding of cell-type specific transcriptomic and epigenomic states of glioma-derived myeloid cells beyond immunosuppressive paradigms remains elusive. Methods To this end, we performed single-cell RNA-sequencing (scRNA-seq) on 140,000 tumor-associated immune cells from eighteen IDH mutation classified primary (N=8) and recurrent (N=10) human gliomas and three non-glioma brains (NGBs). We performed unsupervised clustering and cell annotation based on overlapping canonical lineage and signal dependent transcription factors. Gene ontology and gene set enrichment analyses were performed to define functional states of glioma associated myeloid cells. Results Our analyses revealed twelve myeloid cell types across glioma subgroups. We noted abundant microglial cells in IDHmut than IDHwt gliomas. Concomitantly, continnum of microglia and macrophage phenotypes were observed in IDHwt glioma, which exhibit more severe tumor pathologies. Strikingly, we identified a hybrid microglia/macrophage cell subset with enriched interferon module inferred from our gene ontology analyses. These hybrid phagocytes were significantly increased in recurrent IDHwt gliomas. As tissue macrophages exhibit multifaceted polarization in response to microenvironmental cues, we clarify the existence of microglia/macrophage functional states beyond M1/M2 paradigms exemplified by the presence of palmitic-, oleic- acid, and glucocorticoid responsive polarized states. Specifically, certain microglia and monocyte-derived subpopulations were associated with antigen presentation gene modules, akin to cross-presenting dendritic cells. Furthermore, immune related gene ontology analysis identified enriched antigen presentation and phagocytosis gene modules in distinct microglia-like clusters. Importantly, the phagocytic immunomodulator; Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) was upregulated in these microglia-like cells. Contrary to tumor promoting role of TREM2 myeloid cells in non-brain cancers, we identify TREM2 axis as a regulator of antigen presentation. Additionally, single cell- Assay for Transposase-Accessible Chromatin using sequencing (sc-ATAC-seq) on ~40,000 tumor-associated microglia revealed genes associated with IFN-gamma/IL-12/IL-10 pathway were negatively regulated in IDHmut/IDHwt microglia compared to homeostatic microglia in NGBs. Conclusions In summary, our study sculpts transcriptional and epigenomic details and re-defines glioma-specific immune contexture for downstream immunogenomics applications. We specifically reveal interferon and TREM2 nodes on microglia-like phagocytic cells as clinically tractable anti-glioma immunotherapy target.

A Map of the Spatial Distribution and Tumour-Associated Macrophage States in Glioblastoma and Grade 4 IDH-mutant Astrocytoma.

Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas

The Role of Tumor-Associated Macrophages in Glioma Cohort: Through Both Traditional RNA Sequencing and Single Cell RNA Sequencing.

Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment

Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics

The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential

293 The Impact of Tumor Mutational Status on Protoporphyrin IX Accumulation in Tumor-Associated Macrophages in Glioblastoma Patients

Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma

IMMU-51. SINGLE-CELL ANALYSIS OF TUMOR-ASSOCIATED MICROGLIA AND MACROPHAGES FROM HUMAN GLIOBLASTOMA

Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage

Correlation of Tumor-Associated Macrophage Infiltration in Glioblastoma with Magnetic Resonance Imaging Characteristics: a Retrospective Cross-Sectional Study.

Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype

Microglia and macrophages in glioblastoma: landscapes and treatment directions

Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients

TAMI-31. MACROPHAGE M1 INVASION PREDICTS POOR PROGNOSIS OF GLIOMA AND REVEALS A STRATEGY FOR GLIOBLASTOMA THERAPY

1001 Immunophenotyping of Brain Tumors Identifies Interferon Enriched Phagocytes in Human Gliomas

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Tmic-26. Immune Cell Dynamics Within Gliomas: The Influence Of Grade And Idh Status

Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities

Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights stumor-promoting macrophage cells in Glioblastoma